Samsara BioCapital's Investment in Inventiva S.A.

Samsara BioCapital, L.P., along with Samsara BioCapital GP, LLC and Dr. Srinivas Akkaraju, filed a Schedule 13D to report their investment in Inventiva S.A. The filing details the acquisition of ordinary shares and pre-funded warrants through a multi-tranche private placement. Samsara LP purchased a total of 8,161,942 ordinary shares, 4,645,925 pre-funded warrants, and 6,637,037 performance warrants. The investment was made for the purpose of increasing the value of their holdings. Dr. Akkaraju was appointed to the board of directors of Inventiva following shareholder approval. The filing also notes that Samsara LP sold a portion of its shares in open market transactions in October 2025. The Reporting Persons reserve the right to increase or decrease their holdings based on various factors.